(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

TERAPIA DE COMBINAÇÃO ANTICÂNCER

Em ExigênciaInvention PatentPCT · EP2020058513

Application data

Number

112021016520

Type

Invention Patent

Filing

03/26/2020

Publication

10/26/2021

PCT

EP2020058513

Progress at the INPI

Technical opinion to answer
  1. Filing03/26/20
  2. Publication10/26/21
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 07/28/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ABLYNX N.V.

BE

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

DE

See this company's full portfolio

Inventors

B. D. (pessoa física)

DE

M. B. (pessoa física)

DE

V. Z. (pessoa física)

DE

Technical data

Priority claims

EP

19166375.6 · 03/29/2019

Abstract

TERAPIA DE COMBINAÇÃO ANTICÂNCER. A presente invenção refere-se a terapias anticâncer compreendendo o uso de um polipeptídeo capaz de especificamente se ligar a LRP5 e LRP6 em combinação com um anticorpo anti-PD1, cada uma como aqui descrito.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Parecer de pré-exame

#6.23

07/28/2026

RPI 2899

Transferência deferida

#25.1

07/29/2025

RPI 2847

Notificação de entrada na fase nacional - PCT

#1.3

10/26/2021

RPI 2651

Alteração de dados cadastrais

#1.1

08/31/2021

RPI 2643

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.